Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide® in Leptomeningeal Metastases Monitoring

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/25/2026

1. INTC
2. DECK
3. META
4. AMD
5. INFY
6. RNG
7. SPY
8. TMUS
9. UNP
10. GOOGL

Go back to Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide® in Leptomeningeal Metastases Monitoring
(NASDAQ: PSTV) Delayed: 3.83 +0.05 (1.32%)
Previous Close $3.78    52 Week High $ 
Open $3.81    52 Week Low $ 
Day High $4.00    P/E N/A 
Day Low $3.81    EPS $ 
Volume 64,830